Department of Otorhinolaryngology, Head and Neck Surgery, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Department of Pathology and Molecular Diagnostics, Nagoya City University Graduate School of Medical Sciences, 1-Kawasumi, Mizuho-ku, Nagoya, 467-8601, Japan.
Int J Clin Oncol. 2020 Oct;25(10):1774-1785. doi: 10.1007/s10147-020-01731-9. Epub 2020 Jul 1.
Owing to the low incidence of adenoid cystic carcinoma (AdCC), reliable survival estimates and prognostic factors remained unclarified.
In this multi-institutional retrospective analysis, we collected 192 AdCC cases, and investigated the impact of clinicopathological factors on clinical outcomes of the patients. All AdCC cases were of salivary gland origin and were surgically treated with curative intent. Diagnoses of AdCC were validated by a central pathology review by expert pathologists.
The 5-year overall survival (OS) and disease-free survival (DFS) rates were 92.5 and 50.0%, respectively. Treatment failure occurred in 89 patients (46%) with the distant failures in 65 (34%). Multivariate analysis indicated that pN2 and a pathologically positive surgical margin were independent prognostic factors for both OS and DFS. Histological grade III was an independent prognostic factor for OS. A primary site in the submandibular gland, pT3/4, pN1, and histological grade II were independent prognostic factors for DFS. Postoperative radiation therapy (PORT) improved the locoregional control (LRC) rate. Prophylactic neck dissection was not associated with a better OS or better LRC among patients with cN0. Facial nerve dissection did not improve clinical outcomes in parotid AdCC cases without facial nerve palsy.
A higher TN classification, a pathologically positive surgical margin, and a higher histological grade were associated with a lower OS. PORT improved LRC rates but neck dissection failed to improve clinical outcomes in patients with cN0. As the distant metastasis was frequent, effective systemic therapy is imperative to improve the survival of AdCC patients.
由于腺样囊性癌(AdCC)的发病率较低,可靠的生存估计和预后因素仍不清楚。
在这项多机构回顾性分析中,我们收集了 192 例 AdCC 病例,并研究了临床病理因素对患者临床结局的影响。所有 AdCC 病例均来源于唾液腺,且均以治愈为目的进行了手术治疗。通过专家病理学家的中心病理审查验证了 AdCC 的诊断。
5 年总生存率(OS)和无病生存率(DFS)分别为 92.5%和 50.0%。89 例患者(46%)发生治疗失败,其中远处失败 65 例(34%)。多因素分析表明,pN2 和病理阳性手术切缘是 OS 和 DFS 的独立预后因素。组织学分级 III 是 OS 的独立预后因素。下颌下腺原发灶、pT3/4、pN1 和组织学分级 II 是 DFS 的独立预后因素。术后放射治疗(PORT)改善了局部区域控制(LRC)率。预防性颈部清扫术在 cN0 患者中与 OS 或 LRC 改善无关。对于无面神经瘫痪的腮腺 AdCC 病例,面神经解剖术并未改善临床结局。
较高的 TN 分级、病理阳性手术切缘和较高的组织学分级与较低的 OS 相关。PORT 提高了 LRC 率,但颈部清扫术未能改善 cN0 患者的临床结局。由于远处转移较为常见,有效的全身治疗对于改善 AdCC 患者的生存至关重要。